Skip to main content
SpringerLink
Log in

Cross-reactivities of 39 new amphetamine designer drugs on three abuse drugs urinary screening tests

  • Short Communication
  • Published:
Forensic Toxicology Aims and scope Submit manuscript

Abstract

The detection of illicit drugs is important both in the management of substance misuse and in the postmortem identification of drug abuse. Urinary screening assays have been available for many years, and have been successfully utilized for detecting misuse. Urine remains the biological tool of choice to verify drug-free behavior because of noninvasive sampling and high concentrations of drugs and metabolites. Herein we describe the cross-reactivities of 39 new amphetamine designer drugs on three different on-site abuse drugs urinary screening tests (Screen®7, SureStep™, InstAlert™), which are commonly available in forensic laboratories and in the clinical environment. They are chromatographic immunoassay tests for the qualitative detection of amphetamine, methamphetamine, and methylenedioxymethamphetamine at the recommended cutoff according to Italian legislation (500 ng/ml). The speed and sensitivity of these tests have made them the most widely accepted method to screen urine for drugs of abuse.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Henderson GL (1998) Designer drugs: past history and future prospects. J Forensic Sci 33:569–575

    Google Scholar 

  2. Carroll FI, Lewin AH, Mascarella SW, Seltzman HH, Reddy PA (2012) Designer drugs: a medicinal chemistry perspective. Ann NY Acad Sci 1248:18–38

    Article  CAS  PubMed  Google Scholar 

  3. United Nation Office on Drug and Crime (2011) Amphetamine and ecstasy, Global ATS Assessment

  4. Wada M, Sugimoto Y, Crabtree BL, Evans C, Montgomery JH, Ikeda R, Kuroda N, Nakashima K (2013) Simultaneous determination of amphetamine-type stimulants in abusers’ hair: clinical usefulness of hair analysis in prehospitalization for abusers. Forensic Toxicol 31:2–8

    Article  CAS  Google Scholar 

  5. Pirisi MA, Nieddu M, Burrai L, Carta A, Briguglio I, Baralla E, Demontis MP, Varoni MV, Boatto G (2013) An LC–MS–MS method for quantitative analysis of six trimethoxyamphetamine designer drugs in rat plasma, and its application to a pharmacokinetic study. Forensic Toxicol 31:197–203

    Article  CAS  Google Scholar 

  6. Nieddu M, Burrai L, Pirisi MA, Carta A, Briguglio I, Dessì G, Boatto G (2013) Validated liquid chromatography–mass spectrometry method for the quantitation of N-substituted derivatives of 3,4-methylenedioxyamphetamine in rat urine. Forensic Toxicol 31:204–211

    Article  CAS  Google Scholar 

  7. Nakazono Y, Tsujikawa K, Kuwayama K, Kanamori T, Iwata YT, Miyamoto K, Kasuya F, Inoue H (2013) Differentiation of regioisomeric fluoroamphetamine analogs by gas chromatography–mass spectrometry and liquid chromatography–tandem mass spectrometry. Forensic Toxicol 31:241–250

    Article  CAS  Google Scholar 

  8. Zaitsu K, Miyagawa H, Sakamoto Y, Matsuta S, Tsuboi K, Nishioka H, Katagi M, Sato T, Tatsuno M, Tsuchihashi H, Suzuki K, Ishii A (2013) Mass spectrometric differentiation of the isomers of mono-methoxyethylamphetamines and mono-methoxydimethylamphetamines by GC–EI–MS–MS. Forensic Toxicol 31:292–300

    Article  CAS  Google Scholar 

  9. Shiotsuki T, Yoshitome K, Moriya F (2012) Use of on-site immunoassay devices to screen urine absorbed in disposable diapers for methamphetamine: a preliminary study with artificial urine. Forensic Toxicol 30:162–167

    Article  CAS  Google Scholar 

  10. McLaughlin P, Pounder D, Maskell P, Osselton D (2013) Real-time near-body drug screening during autopsy I: use of the Randox biochip drugs of abuse DOA I and DOA II immunoassays. Forensic Toxicol 31:113–118

    Article  CAS  Google Scholar 

  11. Nieddu M, Trignano C, Burrai L, Pirisi MA, Boatto G (2013) Cross-reactivities of 41 new amphetamine-designer drugs to EMIT® immunoassays. Forensic Toxicol 31:133–137

    Article  CAS  Google Scholar 

  12. Nakanishi K, Miki A, Zaitsu K, Kamata H, Shima N, Kamata T, Katagi M, Tatsuno M, Tsuchihashi H, Suzuki K (2012) Cross-reactivities of various phenethylamine-type designer drugs to immunoassays for amphetamines, with special attention to the evaluation of the one-step urine drug test Instant-View™, and the Emit® assays for use in drug enforcement. Forensic Sci Int 217:174–181

    Article  CAS  PubMed  Google Scholar 

  13. Kerrigan S, Mellon MB, Banuelos S, Arndt C (2011) Evaluation of commercial enzyme-linked immunosorbent assays to identify psychedelic phenethylamines. J Anal Toxicol 35(7):444–451

    Article  CAS  PubMed  Google Scholar 

  14. Decree of the Italian Republic President, no. 309/1990. “Testo unico delle leggi in materia di disciplina degli stupefacenti e sostanze psicotrope, prevenzione, cura e riabilitazione dei relativi stati di tossicodipendenza”.–“Law for the discipline of abuse drugs and psychotropic substances, prevention, treatment and rehabilitation of drug addiction -Italian”. (Italian Official Gazette No. 25/1990, Suppl.Ord. No. 67)

  15. Italian Decree “Provvedimento no. 99/cu del 30/10/2007, Intesa, ai sensi dell’articolo 8, comma 6, della legge 5 giugno 2003, n. 131, in materia di accertamento di assenza di tossicodipendenza–Italian”. “Measure no. 99/cu del 30/10/2007, Agreement for the assessment of a drug addiction status, according to the article 8, comma 6, of the law n. 131 of 05/06/2003”. (Italian Official Gazette No. 266/2007)

  16. Shulgin A, Shulgin A (1991) Pihkal, a chemical love story. Transform Press, Berkeley

    Google Scholar 

  17. Package insert. SureStep™ one-step test strip (urine) for AMP, MET and MDMA; Alere Srl, Milan, Italy

  18. Package insert. InstAlert™ Multi-drug one step screen test panel (urine) for COC/AMP500/MET500/THC/MTD/MDMA/MOP. Biosigma Srl, Venice, Italy

  19. Package insert. Screen®7 multi-drug one step screen test panel (urine) for COC/AMP500/MET500/THC/MTD/MDMA/MOP. SCREEN ITALIA Srl, Perugia, Italy

  20. Italian Decree Provvedimento no. 178/csr del 18/09/2008. Accordo, ai sensi dell’articolo 8, comma 2 dell’Intesa in materia di accertamento di assenza di tossicodipendenza, perfezionata nella seduta della Conferenza Unificata del 30 ottobre 2007-Italian. Measure no. 178 of the 18/09/2008. Agreement according to the article 8, comma 6, of the Unified Conference of 30/10/2007 about the assessment of a drug addiction status. (Italian Official Gazette No. 236/2008)

Download references

Conflict of interest

There are no financial or other relations that could lead to a conflict of interest.

Author information

Authors and Affiliations

  1. Dipartimento di Chimica e Farmacia, Università di Sassari, Via Muroni 23/a, 07100, Sassari, Italy

    Maria Nieddu, Lucia Burrai & Gianpiero Boatto

  2. Dipartimento di Scienze Biomediche, Università di Sassari, Via Matteotti 16, 07100, Sassari, Italy

    Claudia Trignano

Authors
  1. Maria Nieddu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lucia Burrai
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Claudia Trignano
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Gianpiero Boatto
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gianpiero Boatto.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nieddu, M., Burrai, L., Trignano, C. et al. Cross-reactivities of 39 new amphetamine designer drugs on three abuse drugs urinary screening tests. Forensic Toxicol 32, 132–138 (2014). https://doi.org/10.1007/s11419-013-0198-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11419-013-0198-1

Keywords

Search

Navigation